Apogent Shutters BioRobotics Group
Portsmouth, NH-based Apogent Technologies announced that it has discontinued its BioRobotics group, which manufactures and sells automated instrumentation, as part of a corporate restructuring.
The company recorded an after-tax charge totaling $85.9 million for the estimated losses on sales of the discontinued operations, which included its Applied Biotech division, also shuttered.
Apogent acquired the BioRobotics Group, which was established in 1993 and employs over 50 people in the UK and 10 in the US, in March 2001 for an undisclosed sum. Its MicroGrid product was the first commercially available instrument to enable researchers to print their own DNA biochips.
The company’s Apogent Discoveries unit will consolidate its Sunnyvale, Calif., unit with its Hudson, NH, facility and the unit will do business as Matrix Technologies, focusing on liquid handling. The company’s line of PCR consumables will be transferred to AbGene/Marsh BioProducts. The company’s Automation Tips (AutoTips, RoboTips, and QT Tips) products will be transferred to Molecular BioProducts (MBP).
The company’s FlexChem products, Hybridization Incubators, Gemini waterbaths, and TrueTemp Microheating systems) will be discontinued upon selling the last of the inventory, the company said in a letter to customers (http://www.apogentdiscoveries.com/news/news.aspx).
Affymetrix’s Japan Unit Gets Services Partners
Affymetrix Japan, the wholly-owned direct-sales subsidiary of Affymetrix, announced last week that BioMatrix Laboratories, Kurabo Industries, Mitsubishi Chemical Safety Institute, and Takara Bio will become authorized service providers in Japan.
Beginning on June 1, the companies will provide scanning and data analysis of Affymetrix GeneChip-brand microarrays, as well as service and support for GeneChip instrumentation. The company has an installed base of 100 instruments in Japan.
Xpogen Licenses PathlinX Software to Johns Hopkins
Xpogen, a Cambridge, Mass.-based informatics company, said last week that it has licensed its PathlinX 3.0 gene expression-analysis software to Johns Hopkins Medical Center. PathlinX software is designed to identify differentially co-expressed genes in two-state method-of-action experiments.
Strand Genomics Licenses Microarray Software to Singapore Bioprocessing Institute
Strand Genomics of Bangalore, India, has licensed its Soochika microarray data mining and management software to Singapore’s Bioprocessing Technology Institute, the company said earlier this week.
The companies did not provide financial terms of the agreement.
Amersham Biosciences Revamps Service Agreement
Amersham Biosciences said it is revamping its instrumentation service agreement model to give customers more flexibility.
The new service package, called Your Agreement, allows customers to create a customized service plan, with options available for agreement length, response levels, coverage hours, preventative maintenance, parts covered, software upgrades, and computer support and training.
“Traditionally, the one-size-fits-all one- to three- year pre-packaged offers were the standard practice in the drug development industry,” said Nicola Raw, marketing director, service, at Amersham Biosciences, in a statement.
The new model is expected to provide greater flexibility “at a time when our customers are facing capital funding restrictions,” Raw said.
Combimatrix Forms Alliance with Toppan to Develop and Manufacture Arrays
CombiMatrix has formed a strategic alliance with Toppan Printing to develop and manufacture microarrays that use electrochemical detection, the company said.
Toppan of Tokyo, will pay CombiMatrix, a subsidiary of Acacia Research, an upfront fee of $1 million as well as additional development and milestone fees. Toppan will manufacture microarrays for CombiMatrix and its partners, and share revenues and royalties on these chips.
The two companies plan to co-develop semiconductor microarrays for applications in research and diagnostics. Unlike microarrays that CombiMatrix has developed with Roche, which use optical detection, these arrays will rely on electrochemical detection.
CombiMatrix said it has already tested this technology in small prototype instruments and assays for biological and chemical defense applications.